



Miura et al., J Anesth Clin Res 2013, 4:10
http://dx.doi.org/10.4172/2155-6148.1000361
Volume 4 • Issue 10 • 1000361J Anesth Clin ResISSN:2155-6148 JACR an open access journal 
Keywords: Arrhythmia; Ischemia/reperfusion injury; 5-Hydroxy-
decanoate; Preconditioning
Introduction
Lethal injury to the heart can be dramatically blunted by brief 
conditioning periods of ischemia and reperfusion: a phenomenon 
called ischemic preconditioning [1,2]. And brief exposure to a volatile 
anesthetic agent such as isoflurane [3] and sevoflurane [4,5] also 
protects the heart against subsequent ischemia–reperfusion injury. 
This phenomenon has been recognized as anesthetic preconditioning 
[6]. To date, numerous studies have investigated the mechanism of 
cardiac preconditioning, and many crucial components underlying 
cardioprotection have been identified. Adenosine triphosphate-
sensitive potassium (KATP) channels have long been considered as 
essential components of cardioprotection by both ischemic and 
anesthetic preconditioning [7,8]. There are two populations of KATP 
channels in cardiac myocytes: the mitochondrial (mitoKATP) channel 
located in the inner mitochondrial membrane and the sarcolemmal 
(sarc KATP) channel located in the plasma membrane [9]. A role for 
mitochondrial KATP channels in ischemic preconditioning has been 
suggested [10]. As for the role for mitochondrial KATP channels in 
anesthetic preconditioning, our laboratory demonstrated that the 
protective effects by sevoflurane as well as brief ischemia may be 
mediated by mitochondrial rather than sarcolemmal KATP channel 
opening [4].
Although the term “preconditioning” is currently employed 
primarily to describe a limitation of infarct size, subsequent studies 
[6,11] have demonstrated that preconditioning can in some models, 
afford protection against ischemia/reperfusion- induced arrhythmias. 
It remains to be determined, however, if antiarrhythmic protection is a 
direct consequence of anti-ischemic protection and if the mechanisms 
involved are the same as those involved in protection against infarction. 
Also, it is little known whether ischemic preconditioning and anesthetic 
preconditioning have antiarrhythmic effects or not, and whether KATP 
channels are related to arrhythmias during acute myocardial ischemia 
and reperfusion especially in rabbit hearts. 
The present study, therefore, aimed to investigate whether ischemic 
or sevoflurane-induced preconditioning exerts infarct size limiting 
effects and depresses ischemia-reperfusion arrhythmias through 
opening of mitochondrial KATP channels in rabbits in vivo. 
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Abstract
Objectives: The present study aimed to investigate whether ischemic or sevoflurane-induced preconditioning 
exerts infarct size limiting effects and depresses ischemia-reperfusion arrhythmias through opening of mitochondrial 
KATP channels in rabbits in vivo.
Methods: Rabbits anesthetized with ketamine and xylazine given intramuscularly underwent 30 min of left 
anterior descending coronary artery (LAD) occlusion followed by 3 hrs of reperfusion. Before this, rabbits were 
randomized into one of five groups. Control rabbits received no intervention before 30 min LAD occlusion and 3 h 
reperfusion (Group-C). The ischemia-preconditioned (IP) rabbits underwent 5 min LAD occlusion followed by 10 min 
of reperfusion before prolonged ischemia-reperfusion (Group-IP). In the sevoflurane (S)–preconditioned group, 30 
min of sevoflurane exposure at a 1.5% end-tidal concentration was followed by 15 min of washout before prolonged 
ischemia-reperfusion (Group-S). The selective mitochondrial KATP channel blocker, 5-hydroxy-decanoate (5-HD, 5 
mg/kg) was given intravenously 10 min before ischemic preconditioning and sevoflurane exposure, respectively 
(Group-5-HD-IP, Group-5-HD-S). An electrocardiogram was recorded throughout the experiment via lead 2 of the 
standard electrocardiogram. At the end of the 3 hrs reperfusion period, area at risk (R) and infarct size (I) were 
measured. 
Results: RPP decreased in Group-5-HD-IP and Group-5-HD-S compared with Group-S at 30 min after ischemia. 
The ratio of R to left ventricular mass showed no significant difference among all groups. I/R values of each group 
were 51.6 ± 3.0% in Group-C, 33.3 ± 4.7% in Group-IP, 36.6 ± 4.8% in Group-S, 48.9 ± 5.2% in Group-5-HD-IP, 54.8 
± 4.2% in Group-Group-5-HD-S. There was no significant difference in duration of arrhythmias during myocardial 
ischemia and reperfusion among 5 groups.
Conclusion: Ischemic preconditioning and sevoflurane-induced preconditioning exert infarct size limiting 
effects through opening of mitochondrial KATP channels. However, ischemic preconditioning and sevoflurane-induced 
preconditioning do not have antiarrhythmic effects. This suggests that the opening of mitochondrial KATP channels 
does not cause antiarrhythmic effects.
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Materials and Methods
The present study was performed in accordance with the Guidelines 
of Animal Care and Use Committee of Kanagawa Dental University.
General surgical preparation
Male New Zealand White rabbits weighing 2.7-3.2 kg were allowed 
ad libitum access to standard laboratory stock diet and water. Animals 
were initially anesthetized with ketamine (35 mg/kg) and xylazine 
(5 mg/kg) given intramuscularly. Tracheotomy was performed and 
rabbits were intubated with an uncuffed endotracheal tube (ID 3.5 
mm). The animals were ventilated with room air supplemented with 
additional oxygen. Inspired and expired anesthetic concentration, 
inspiratory O2 percentage and end-tidal CO2 partial pressures were 
continuously monitored using a multigas anesthetic monitor (Datex, 
Capnomac, Helsinki, Finland). The respiratory rate was frequently 
adjusted to maintain PaO2 greater than 100 mm Hg, PaCO2 at 35-45 
mm Hg, pH 7.35-7.45, and Base Excess between -3 and +3. After the 
left jugular vein was exposed and cannulated with a polyethylene 
catheter, 0.9% sodium chloride (0.15 ml/min) was continually 
administered during the experiments. The carotid artery was dissected 
out and fluid-filled polyethylene tube was placed in it and connected 
immediately to an electrocardiogram monitor (Nihon-kohden Co, 
Life scope 11, Tokyo, Japan) via pressure transducer (Nihon-kohden 
Co, TP-400T, Tokyo, Japan) for arterial pressure recording. An 
electrocardiogram was recorded throughout the experiment via lead 
II of the standard electrocardiogram. Ischemia or reperfusion-induced 
arrhythmias included premature ventricular contraction (PVC) and 
ventricular tachycardia (VT). Left thoracotomy was performed and 
pericardium was opened to expose the heart. A silk thread (K-890H, 
Ethicon, Somerville, NJ) with taper C-1 needle was passed around 
the left anterior descending artery (LAD) and the end of the tie were 
threaded through a small vinyl tube to form a snare. The LAD was 
occluded by pulling the snare, which was then fixed by clamping the 
tube with a mosquito hemostat. Myocardial ischemia was confirmed by 
regional cyanosis, ST segment elevation and decreased blood pressure. 
Reperfusion was confirmed by reactive hyperemia over the surface 
after releasing the snare.
Study groups and experimental protocol
Figure 1 presents study groups and experimental protocol. 
Anesthesia was maintained with ketamine and xylazine solution 
(ketamine 35 mg/kg/hr, xylazine 5 mg/kg/hr i.m.; k/x) with room 
air supplemented with additional pure oxygen. After all the surgical 
procedures had been performed, a 15 min period was allowed for 
stabilization. All anesthetized open-chest rabbits underwent 30 min of 
left anterior descending coronary artery (LAD) occlusion followed by 3 
hrs of reperfusion. Before this, the animals were randomized into one 
of the following experimental protocols:
Control rabbits received no intervention before 30 min LAD 
occlusion and 3 hrs reperfusion (Group-C; n=9). The ischemia-
preconditioned (IP) rabbits underwent 5 min LAD occlusion followed 
by 10 min of reperfusion before prolonged ischemia-reperfusion 
(Group-IP; n=10). In the sevoflurane (S)–preconditioned group, 30 
min of sevoflurane exposure at a 1.5% end-tidal concentration was 
followed by 15 min of washout before prolonged ischemia-reperfusion 
(Group-S, n=6). The selective mitochondrial KATP channel blocker, 
5-hydroxy-decanoate (5-HD, 5 mg/kg) was given intravenously 10 min 
before ischemic preconditioning and sevoflurane exposure, respectively 
(Group-5-HD-IP; n=6, Group-5-HD-S; n=6). At the end of the 3 hrs 
reperfusion period, area at risk and infarct size were measured.
Hemodynamic measurements
Hemodynamic measurements included systolic, diastolic, mean 
arterial blood pressures and heart rate. Rate pressure product was 
calculated as the product of heart rate and peak arterial pressure. 
Baseline hemodynamic measurements were taken prior to any 
experimental manipulations. Subsequently, the measurements were 
taken at 29 min of ischemia and 30, 60 and 180 min of reperfusion.
Determination of area at risk and infarct size 
Following completion of experimental protocol, the in vivo 
visualization of the myocardium at risk was accomplished with 
reocclusion of the coronary artery and injection of 10% Evans blue 
into the venous cannula until the eyes turned blue. The Evans blue was 
allowed to circulate for about 30 sec to demarcate the risk and non-
risk regions. The hearts were quickly excised under deep anesthesia 
and frozen. The frozen hearts were then cut into six transverse slices 
of equal thickness. The area at risk was determined by negative 
staining with Evans blue. The slices were stained by incubation for 15 
min in 1% triphenyl tetrazolium chloride (TTC) in isotonic pH 7.4 
phosphate buffer. After staining, the sections were placed in formalin 
for preservation, and measurements of risk area, infarct area and left 
ventricle were made with computer aided morphometry. From each 
section, the ischemic area at risk (unstained by blue dye) and the 
infarcted area (unstained by TTC) were outlined and measured by 
planimetry. The area from each region was averaged from the slices. 
Infarct size was expressed both as a percentage of total left ventricular 
mass (L) and as a percentage of the ischemic risk area. This method has 
generally been found to be an accurate measure of ultimate infarct size 
at 2 to 48 hr of reperfusion when compared with subsequent histologic 
analysis [12,13].
Rabbits which could not be survived until the end of experiments 
with lethal arrhythmias such as ventricular fibrillation (VF) have 
excluded from the data analysis and not considered further.
Statistical Analysis 
Statistical comparisons of individual hemodynamic parameters 
between groups were made using one-way ANOVA followed by 
Fisher’s protected least significant difference. Bartlett’s test for equality 
of variances was used to ensure the validity of statistical comparison 
using the one-way ANOVA. Statistical comparisons of infarct size/area 
Figure 1: Schematic diagram of the protocol. Group-C: a control group (n=9). 
Group-IP: a ischemia-preconditioned group (n=10). Group-S: a sevoflurane-
preconditioned group (n=6). Group-5-HD-IP: a group which was given 5HD 10 
min before ischemic preconditioning (n=6). Group-5-HD-S: a group which was 
given 5HD 10 min before sevoflurane exposure (n=6).
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at risk, area at risk/left ventricle, and duration of arrhythmias between 
groups were made using an ANOVA and Kruskal-Wallis test followed 
Dunn procedure. All data are reported as group mean ± SEM, and were 
considered statistically significant at a probability value (P) less than 
0.05.
Results
Rate pressure product (RPP) is shown in Table 1. RPP decreased 
in Group-5-HD-IP and Group-5-HD-S compared with Group-S at 
30 min after ischemia. The ratio of areas at risk (R) to left ventricular 
mass (L) ranged from 54.0 ± 4.9% to 66.1 ± 5.3% with no significant 
difference among all the groups (Figure 2). Figure 3 shows the infarct 
size (I) expressed as percentage of area at risk (R) in five groups. 
I/R values of each group were 51.6 ± 3.0% in Group-C, 33.3 ± 4.7% 
in Group-IP, 36.6 ± 4.8% in Group-S, 48.9 ± 5.2% in Group-5-HD-
IP, 54.8 ± 4.2% in Group-Group-5-HD-S. The mean infarct sizes 
in Group-IP and Group-S were significantly smaller than that of 
Group-C. Infarct size in Group-IP was significantly smaller compared 
with that of Group-5-HD-IP. The mean infarct sizes in Group-IP and 
Group-S were significantly smaller than that of Group-5-HD-S. The 
duration of arrhythmias during myocardial ischemia were 91.4 ± 
37.0 sec in Group-C, 55.7 ± 32.6 sec in Group-IP, 30.1 ± 20.5 sec in 
Group-S, 42.4 ± 26.8 sec in Group-5-HD-IP, 35.0 ± 22.5 sec in Group-
5-HD-S (Figure 4). The duration of arrhythmias during reperfusion 
were 200.5 ± 39.1 sec in Group-C, 127.4 ± 41.4 sec in Group-IP, 151.0 
± 35.7 sec in Group-S, 153.0 ± 99.4 sec in Group-5-HD-IP, 80.5 ± 38.3 
sec in Group-5-HD-S (Figure 5). There was no significant difference in 
duration of arrhythmias during myocardial ischemia and reperfusion 
among 5 groups.
Discussion
In the present study, both ischemic and sevoflurane-induced 
preconditioning also reduced infarct size, and 5-HD, an effective 
blocker of mitochondrial KATP channels abolished infarct size limiting 
effect. Our previous study [14] in the same experimental system and 
other studies [15-17] have demonstrated that 5-HD alone caused no 
significant changes in myocardial infarct size and hemodynamics. These 
results and observations suggest that both ischemic and sevoflurane-
induced preconditioning exerted infarct size limiting effect through 
opening of mitochondrial KATP channels. Thus, the cardioprotection 
by ischemic and sevoflurane-induced preconditioning may be 
mediated, at least in part, by mitochondrial KATP channel. However, 
ischemic preconditioning and sevoflurane-induced preconditioning 
did not have anti-arrhythmic effects. In this experiment, ischemia 
may result in increased potassium ion (K+) efflux and accumulation of 
extracellular K+, and leads to produce arrhythmias. The mechanisms 
underlying reperfusion-induced arrhythmias seem to be different from 
those responsible for the induction of ischemia-induced arrhythmias. 
These include oxygen free radicals and increased levels of intracellular 
calcium [18].
Protection of ischemic preconditioning against arrhythmias is 
somewhat controversial and varies dependent on species [19]. It 
was reported that ischemic preconditioning decreased incidence 
of arrhythmias in in vivo rats [20-22] and dogs [11,23]. Also, it was 
suggested that the protective effect of ischemic preconditioning against 
arrhythmias is not likely to be involved in activation of KATP potassium 
channels during ischemia [20]. On the contrary, in in vivo dogs, possible 
mechanism of antiarrhythmic action by ischemic preconditioning is 
related to opening of mito KATP channels [22,23].
In the rabbit model, in which collateral flow is negligible [24], 
protection of ischemic preconditioning against arrhythmias was 
not observed. And as far as we have investigated, there have been no 
references that ischemic preconditioning has antiarrhythmic effect 
during ischemia and reperfusion in in vivo rabbit hearts.
As for anesthetic preconditioning, Kevin and Novalija suggested 
that isoflurane-induced preconditioning reduced the incidence of 
arrhythmia in in vitro rat hearts [6].
In this study, sevoflurane-induced preconditioning did not reduce 
ischemia-reperfusion arrhythmias. It may be due to the differences of 
species, length of ischemia and reperfusion, the choice of anesthetics, 
timing and concentration of anesthetics exposure and extent of 
collateral blood flow.
It has been reported that pretreatment with nicorandil and 
pinacidil, both KATP channel openers administered just prior to coronary 
occlusion resulted in protection against ischemia/reperfusion-induced 
arrhythmias in anesthetized rabbits due to activation of cardiomyocyte 
mitochondrial KATP channels. KATP channel openers may shorten the 
action potential duration, thereby reducing cellular calcium overload 
Figure 2: The figure shows R/L value (%), which means the area at risk 
expressed as percentage of left ventricle. Data are expressed as mean ± SEM. 
Area at risk revealed no significant difference among all groups, suggesting 
that the changes in the infarct size observed among the groups did not depend 
on R/L. Group-C: a control group (n=9). Group-IP: a ischemia-preconditioned 
group (n=10). Group-S: a sevoflurane-preconditioned group (n=6). Group-5-
HD-IP: a group which was given 5HD 10 min before ischemic preconditioning 
(n=6). Group-5-HD-S: a group which was given 5HD 10 min before sevoflurane 
exposure (n=6).
Pre-Ischemia 30 min after Ischemia 30 min after 
Reperfusion
60 min after 
Reperfusion
180 min after 
Reperfusion
Group -C 13712.1 ± 864.9 12936.6 ± 455.2 13050.2 ± 840.3 13012.1 ± 788.5 112101.7 ± 733.3
Group -IP 13396.4 ± 987.4 13253.9 ± 845.4 12731.9 ± 924.0 12966.1 ± 863.8 11552.1 ± 793.0
Group-S 13769.3 ± 692.8 14906.7 ± 1071.2 14532.5 ± 1403.8 14151.2 ± 1978.1 10365.0 ± 1868.9
Group -5-HD-IP 12615.0 ± 769.8 12183.2 ± 529.3* 12441.5 ± 498.4 11980.0 ± 442.8 11449.7 ± 654.7
Group-5-HD-S 13501.8 ± 1100.3 11948.5 ± 928.9* 12303.0 ± 922.1 11969.8 ± 758.2 11368.8 ± 853.1
*Significantly different (P<0.05) from Group-S (mean ± SEM) 
Table1: Rate pressure product during ischemia and reperfusion.
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and preserving viability in ischemic/reperfused myocardium, which 
was initially proposed as the mechanism for protection of ischemic 
myocardium [25].
Antiarrhythmic protection must be the manifestation of a 
preservation of ionic homeostasis, whereas the essential requirements 
for protection against necrosis may be different. Indeed, from many 
of the studies, it is clear that it is possible to protect against necrosis 
without the prevention of arrhythmias and vice versa [26].
In the present investigation, though ischemic and sevoflurane-
induced preconditioning reduced infarct size through opening 
of mitochondrial KATP channels, it offered no protection against 
arrhythmias during ischemia and reperfusion.
From these observations, unlike nicorandil and pinacidil, ischemic 
preconditioning and this dose of sevoflurane might not open KATP 
channel enough to exert antiarrhythmic action.
In summary, the present study indicates that ischemic 
preconditioning and sevoflurane-induced preconditioning exert 
infarct size limiting effects through opening of mitochondrial KATP 
channels. However, ischemic preconditioning and sevoflurane-
induced preconditioning do not have antiarrhythmic effects.
This suggests that the opening of mitochondrial KATP channels by 
ischemic preconditioning and sevoflurane-induced preconditioning 
may not be enough to cause antiarrhythmic effects in in vivo rabbit 
hearts even though there is the common mechanism responsible for 
both infarct limiting and antiarrhythmic effects.
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